In this week's podcast, Martin Bachmann discusses results of a phase II study showing how a vaccine to inhibit angiotensin II is safe and well tolerated; the vaccine also shows promising results in reducing blood pressure for people with hypertension. Authors of a Comment state: "Vaccination for hypertension may turn out to be very useful in many patients."

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv